Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
USA (IPDGC-NIA) C UKPDSBB CL 937 (40%) 1896 (53%) 58 (13) - - - 63 (10) - 9,622

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs3851786 chr17:45046932 GOSR2 G vs. A All: C 15 108,990 0.458 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-42) 9.57e-06
rs3851787 chr17:45046982 GOSR2 G vs. A All: C 15 108,990 0.467 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-45) 7.72e-06
rs9893713 chr17:45047380 GOSR2 G vs. A All: C 15 108,990 0.475 (G) 0.433 (G) 0.93 (0.90-0.96) 0 (0-40) 6.78e-06
rs4968290 chr17:45047384 GOSR2 C vs. T All: C 15 108,990 0.492 (C) 0.45 (C) 0.92 (0.89-0.96) 0 (0-33) 4.39e-06
rs7216991 chr17:45052253 GOSR2 G vs. A All: C 15 108,990 0.483 (G) 0.458 (G) 0.93 (0.90-0.96) 0 (0-52) 3.34e-06
rs62075896 chr17:45053590 GOSR2 C vs. T All: C 15 108,990 0.483 (C) 0.45 (C) 0.93 (0.90-0.96) 0 (0-52) 2.62e-06
rs8079694 chr17:45056928 GOSR2 C vs. T All: C 15 108,990 0.367 (C) 0.275 (C) 1.09 (1.05-1.13) 0 (0-52) 7.46e-06
rs8080518 chr17:45057481 GOSR2 C vs. T All: C 15 108,990 0.208 (C) - 0.93 (0.89-0.96) 0 (0-45) 6.07e-05
rs35246578 chr17:45062049 GOSR2 A vs. T All: C 15 108,990 0.367 (A) 0.158 (A) 1.10 (1.06-1.15) 0 (0-52) 8.19e-07
rs4572469 chr17:45064523 GOSR2 T vs. C All: C 15 108,990 - - 1.08 (1.04-1.11) 0 (0-51) 6.95e-06
rs3851798 chr17:45066267 GOSR2 G vs. A All: C 15 108,990 0.425 (G) 0.233 (A) 0.93 (0.90-0.96) 0 (0-51) 9.99e-06
rs2316758 chr17:45066365 GOSR2 C vs. T All: C 15 108,990 0.425 (C) 0.233 (T) 0.93 (0.90-0.96) 0 (0-50) 9.90e-06
rs3851799 chr17:45066488 GOSR2 T vs. C All: C 15 108,990 0.425 (T) 0.233 (C) 0.93 (0.90-0.96) 0 (0-50) 8.44e-06
rs11653589 chr17:45067665 GOSR2 C vs. T All: C 15 108,990 0.433 (C) 0.233 (T) 0.93 (0.90-0.96) 0 (0-50) 1.00e-05
rs8068715 chr17:45068388 GOSR2 A vs. C All: C 15 108,990 0.442 (A) 0.233 (C) 0.93 (0.90-0.96) 0 (0-50) 1.03e-05
rs12949446 chr17:45071677 GOSR2 G vs. A All: C 15 108,990 0.417 (G) 0.242 (A) 0.93 (0.90-0.96) 0 (0-50) 1.06e-05
rs12952596 chr17:45071685 GOSR2 A vs. G All: C 15 108,990 0.442 (A) 0.242 (G) 0.93 (0.90-0.96) 0 (0-50) 1.03e-05
rs12938690 chr17:45075365 GOSR2 A vs. G All: C 15 108,990 0.442 (A) 0.233 (G) 0.93 (0.90-0.96) 0 (0-51) 1.24e-05
rs2316329 chr17:45080048 GOSR2 G vs. A All: C 15 108,990 0.408 (G) - 1.10 (1.05-1.14) 0 (0-26) 1.42e-05
rs6416935 chr17:60184914 MED13 [+42271bp] G vs. T All: C 15 108,990 - - 0.91 (0.87-0.95) 12 (0-50) 3.27e-05
rs11657294 chr17:60186535 MED13 [+43892bp] G vs. A All: C 15 108,990 - - 0.91 (0.87-0.95) 11 (0-48) 4.01e-05
rs7210244 chr17:60187719 MED13 [+45076bp] A vs. G All: C 15 108,990 0.117 (A) - 1.10 (1.05-1.15) 16 (0-53) 4.23e-05
rs8067362 chr17:60187986 MED13 [+45343bp] C vs. T All: C 15 108,990 - - 0.91 (0.87-0.95) 15 (0-53) 4.27e-05
rs6504084 chr17:60188441 MED13 [+45798bp] A vs. G All: C 15 108,990 0.117 (A) 0.5 (A) 1.10 (1.05-1.15) 16 (0-54) 4.19e-05
rs148534175 chr17:60198200 intergenic C vs. T All: C 15 108,990 - - 0.92 (0.88-0.96) 33 (0-64) 8.08e-05
rs74894391 chr17:60198760 intergenic G vs. A All: C 15 108,990 0.1 (G) 0.358 (G) 1.10 (1.05-1.15) 32 (0-64) 9.43e-05
rs4522464 chr17:60199130 intergenic G vs. T All: C 15 108,990 0.1 (G) 0.35 (G) 1.09 (1.05-1.14) 33 (0-64) 8.46e-05
rs2376585 chr17:76417883 PGS1 T vs. C All: C 15 108,990 0.225 (T) 0.042 (T) 0.92 (0.88-0.96) 0 (0-32) 2.94e-04
rs4969188 chr17:76422473 DNAH17 T vs. C All: C 15 108,990 0.258 (T) 0.042 (T) 0.92 (0.88-0.96) 0 (0-33) 5.75e-05
rs341237 chr18:6401283 L3MBTL4 T vs. C All: C 15 108,990 0.333 (T) 0.442 (T) 0.94 (0.91-0.97) 52 (13-73) 6.37e-05
rs2123311 chr18:6403285 L3MBTL4 A vs. G All: C 15 108,990 0.358 (A) 0.392 (A) 0.94 (0.91-0.97) 39 (0-67) 3.62e-05
rs140873114 chr18:30175265 intergenic C vs. T All: C 10 89,302 - - 0.46 (0.30-0.68) 0 (0-33) 1.50e-04
rs142941943 chr18:30196807 intergenic C vs. T All: C 9 86,539 - - 0.45 (0.30-0.67) 0 (0-36) 9.96e-05
rs140172618 chr18:30200272 intergenic C vs. T All: C 9 86,539 - - 0.45 (0.30-0.67) 0 (0-36) 9.98e-05
rs142575749 chr18:40506485 RIT2 C vs. A All: C 12 96,250 - - 1.12 (0.87-1.45) 3 (0-59) 0.369
rs9951372 chr18:40541827 RIT2 A vs. C All: C 15 108,990 0.192 (A) - 1.09 (1.05-1.14) 37 (0-66) 6.99e-05
rs1944418 chr18:40543077 RIT2 G vs. T All: C 15 108,990 0.217 (G) - 1.09 (1.05-1.13) 23 (0-58) 3.19e-05
rs1789622 chr18:40546914 RIT2 C vs. A All: C 15 108,990 0.242 (C) - 1.08 (1.04-1.12) 25 (0-59) 1.33e-04
rs9957165 chr18:40550511 RIT2 C vs. A All: C 15 108,990 0.2 (C) - 1.09 (1.05-1.14) 34 (0-65) 6.77e-05
rs2213052 chr18:40556131 RIT2 T vs. C All: C 15 108,990 0.2 (T) - 1.08 (1.04-1.13) 29 (0-62) 2.76e-04
rs11082301 chr18:40560697 RIT2 A vs. G All: C 15 108,990 0.2 (A) - 1.09 (1.04-1.14) 34 (0-65) 8.25e-05
rs4890420 chr18:40562282 RIT2 A vs. G All: C 15 108,990 0.208 (A) - 1.09 (1.05-1.14) 38 (0-67) 8.21e-05
rs66935716 chr18:40571210 RIT2 A vs. T All: C 15 108,990 0.1 (A) 0.358 (A) 1.03 (0.98-1.09) 0 (0-54) 0.259
rs35263476 chr18:40593791 RIT2 T vs. C All: C 15 108,990 0.383 (T) 0.4 (C) 1.09 (1.05-1.12) 48 (6-72) 1.16e-06
rs7239931 chr18:40596894 RIT2 T vs. C All: C 15 108,990 0.333 (T) 0.408 (C) 1.09 (1.05-1.13) 43 (0-69) 2.63e-06
rs9962882 chr18:40601298 RIT2 C vs. T All: C 15 108,990 0.225 (C) 0.242 (C) 1.09 (1.05-1.14) 31 (0-63) 2.65e-05
rs12970288 chr18:40606344 RIT2 A vs. C All: C 15 108,990 - - 0.92 (0.89-0.95) 47 (4-71) 6.97e-07
rs12969383 chr18:40624981 RIT2 C vs. T All: C 15 108,990 0.467 (C) 0.05 (T) 1.06 (1.03-1.10) 36 (0-66) 3.18e-04
rs11664719 chr18:40640843 RIT2 T vs. C All: C 15 108,990 0.175 (T) - 1.09 (1.04-1.14) 32 (0-63) 1.01e-04
rs139943944 chr18:40642391 RIT2 C vs. T All: C 3 6,995 - - 1.33 (0.17-10.32) 0 (-) 0.786